Literature DB >> 31115754

Understanding the Prevalence of Smoking Among People Living with HIV (PLHIV) in Australia and Factors Associated with Smoking and Quitting.

Stephanie K Edwards1, Judith Dean2, Jennifer Power3, Peter Baker2, Coral Gartner2.   

Abstract

Understanding contributors to smoking and quitting cigarettes is important to developing effective cessation programs and addressing smoking related morbidity and mortality among people living with HIV (PLHIV). Using data from a large cross-sectional study of Australian PLHIV we provide a smoking prevalence estimate and explore the relationship between socio-demographic variables and smoking status. We also explore the relationship between HIV diagnosis and antiretroviral therapy (ART) initiation and quitting smoking. Of the 1011 respondents included in the analysis, 30.6% were current smokers. The strongest predictor of smoking was regular cannabis use (AOR 6.2, 95% CI 3.6-10.8) while the strongest predictor of being a past smoker was receiving ART (AOR 2.4, 95% CI 1.2-4.7). Quitting also increased around the time of diagnosis and ART initiation, highlighting the potential for these events to be optimal times to address smoking among PLHIV.

Entities:  

Keywords:  Cessation; Cigarettes; HIV; Quitting; Smoking

Year:  2020        PMID: 31115754     DOI: 10.1007/s10461-019-02535-3

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  2 in total

1.  HCV Cure and Cannabis Abstinence Facilitate Tobacco Smoking Quit Attempts in HIV-HCV Co-Infected Patients (ANRS CO13 HEPAVIH Cohort Study).

Authors:  Tangui Barré; Patrick Mercié; Fabienne Marcellin; Laure Esterle; Claudine Duvivier; Elina Teicher; Morgane Bureau; Julie Chas; Dominique Salmon-Céron; Philippe Sogni; Maria Patrizia Carrieri; Linda Wittkop; Camelia Protopopescu
Journal:  AIDS Behav       Date:  2021-04-27

2.  Tobacco Use among HIV-Positive and HIV-Negative Women and Men in Zambia-Demographic and Health Survey, 2018.

Authors:  Alissa C Kress; Carlen Stadnik; Masauso Moses Phiri; Fastone M Goma; Evelyn Twentyman
Journal:  Int J Environ Res Public Health       Date:  2022-03-24       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.